Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,951 public trials 2,018 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Active, Not Recruiting

CASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene

NCT00710892

Conditions: Acute Lymphoblastic Leukemia, Bone Marrow Diseases, Chronic Disease, +28 more
Locations: Texas Children's Hospital Houston, Texas, United States

The Methodist Hospital Houston, Texas, United States

View Trial Details

Active, Not Recruiting

A Study of Belantamab Mafodotin Monotherapy in Multiple Myeloma Participants With Normal and Varying Degree of Impaired Renal Function

NCT04398745

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +25 more
Locations: GSK Investigational Site Athens, Greece

GSK Investigational Site Athens, Greece

GSK Investigational Site Busan, South Korea

GSK Investigational Site Seoul, South Korea

View Trial Details

Active, Not Recruiting

Total Marrow and Lymphoid Irradiation and Chemotherapy Before DSCT in Treating Patients With High-Risk ALL or AML

NCT02094794

Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +22 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, Not Recruiting

Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

NCT04162210

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: GSK Investigational Site Tucson, Arizona, United States

GSK Investigational Site Pueblo, Colorado, United States

GSK Investigational Site Detroit, Michigan, United States

GSK Investigational Site Omaha, Nebraska, United States

View all 136 locations

View Trial Details

Active, Not Recruiting

Administration of Donor T Cells With the Caspase-9 Suicide Gene

NCT01494103

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +39 more
Locations: Texas Children's Hospital Houston, Texas, United States

The Methodist Hospital Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Economic Analysis of Alliance A041202 CLL Study

NCT02414022

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: Tom Baker Cancer Centre Calgary, Alberta, Canada

The Moncton Hospital Moncton, New Brunswick, Canada

Health Sciences North Greater Sudbury, Ontario, Canada

Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada

View all 15 locations

View Trial Details

Active, Not Recruiting

Polatuzumab Vedotin (Pola) Plus Rituximab (R) in Patients With Post-transplant Lymphoproliferative Disorder (PTLD)

NCT06040320

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Active, Not Recruiting

Study of CD19/CD22 Chimeric Antigen Receptor T Cells in Children & Young Adults w/ Recurrent or Refractory B Cell Malignancies

NCT03241940

Conditions: B Acute Lymphoblastic Leukemia, Burkitt Lymphoma, CD19 Positive, +29 more
Locations: Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States

View Trial Details

Active, Not Recruiting

Tazemetostat in Combination With Zanubrutinib and Anti-CD20 Monoclonal Antibody in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

NCT06824701

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Huntsman Cancer Institute at University of Uta Salt Lake City, Utah, United States

View Trial Details

Active, Not Recruiting

Implementation and Evaluation of an Internet-Based Stress Management Program for Health Students in the Sfax Region

NCT07123311

Conditions: Anxiety Depression (Mild or Not Persistent), Behavior, Hemic and Lymphatic Diseases, +11 more
Locations: Faculties of Sealth Sciences Sfax, Tunisia

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions